Abstract Number: 1164 • 2016 ACR/ARHP Annual Meeting
Impact of E-Learning on Knowledge, Self-Efficacy and Exercise Behaviours of Patients with Axial Spondyloarthritis: Results from a Longitudinal Randomized Control Trial
Background/Purpose: There is a growing body of evidence to support the effectiveness of education programs for patients with arthritis. Despite this, there has been little development…Abstract Number: 1165 • 2016 ACR/ARHP Annual Meeting
The Development of an Interdisciplinary Treatment Program for Fibromyalgia in a Tertiary Medical Center Focused upon Rheumatology and Internal Medicine
Background/Purpose: Fibromyalgia syndrome (FMS) appears to be undertreated despite the mounting evidence to support the efficacy of interdisciplinary treatment. Why are patients not receiving effective…Abstract Number: 1166 • 2016 ACR/ARHP Annual Meeting
Survey on the Understanding and Practice of T2T for Nurses Engaged in Medical Treatment of Rheumatoid Arthritis
Background/Purpose: In order to achieve treatment goals in patients with rheumatoid arthritis (RA), the guidance for “treatment to target (T2T) by measuring disease activity and…Abstract Number: 1167 • 2016 ACR/ARHP Annual Meeting
Incidence of Primary Chronic Cutaneous Lupus Erythematosus in a Metropolitan Area of the Southeastern United States: The Georgia Lupus Registry
Background/Purpose: Chronic cutaneous lupus erythematosus CCLE is a group of immune mediated inflammatory disorders of the skin that often induce permanent disfigurement, leading to a…Abstract Number: 1168 • 2016 ACR/ARHP Annual Meeting
The Epidemiology of Individuals Not Fully Meeting Classification Criteria for Systemic Lupus Erythematosus (SLE): The Georgia Lupus Registry
Background/Purpose: Identifying individuals as early as possible in the development of an autoimmune disease may lead to important opportunities. This study utilizes an established population-based…Abstract Number: 1169 • 2016 ACR/ARHP Annual Meeting
A Systematic Review of Rheumatic Disease Epidemiology in the Indigenous Populations of Canada, the United States, Australia and New Zealand
Background/Purpose: Two important reviews have summarized the epidemiology of rheumatic disease (Peschken 1999) and RA (Ferucci 2005) in Indigenous populations of North America. Our objective…Abstract Number: 1170 • 2016 ACR/ARHP Annual Meeting
Month of Birth Affects the Risk of Rheumatic Diseases: A Nationwide Case-Control Study
Background/Purpose: There have been several studies which demonstrated the impact of birth on the risk of certain diseases such as asthma or cardiovascular diseases. However,…Abstract Number: 1171 • 2016 ACR/ARHP Annual Meeting
Obesity and the Risk of Systemic Lupus Erythematosus in the Nurses’ Health Studies
Background/Purpose: Obesity has become alarmingly common over the past four decades in the U.S., with a notable rise in obesity prevalence starting in the late…Abstract Number: 1172 • 2016 ACR/ARHP Annual Meeting
Azathioprine and Mycophenolate Mofetil Adherence in a Nationwide Medicaid Cohort with Systemic Lupus Erythematosus
Background/Purpose: Azathioprine (AZA) and mycophenolate mofetil (MMF) are commonly used immunosuppressants for moderate-to-severe SLE. Overall adherence among SLE patients has been shown to be poor…Abstract Number: 1173 • 2016 ACR/ARHP Annual Meeting
Screening for Depression and Anxiety in an Outpatient Rheumatology Clinic Using Validated Self-Applied Questionnaires
Background/Purpose: Anxiety and depression are often present in chronic rheumatic diseases. Recognition of these psychological disorders is fundamental for proper patient management. The absence of…Abstract Number: 1174 • 2016 ACR/ARHP Annual Meeting
Perceived Stress and Reported Cognitive Symptoms Among Patients with Systemic Lupus Erythematosus
Background/Purpose: Higher stress is associated with lower cognitive functioning in many populations. We examined associations of perceived stress with cognitive symptoms among adults with systemic…Abstract Number: 1175 • 2016 ACR/ARHP Annual Meeting
Thirty Day Readmission Rates for Patients Diagnosed with Systemic Lupus Erythematosus: Analysis at a Tertiary Care Center
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic illness that has been associated with high hospital readmission rates. Based on a recently published (Arth Rheumatol…Abstract Number: 1176 • 2016 ACR/ARHP Annual Meeting
Prevalence of Influenza and Pneumococcal Polysaccharide Vaccine Administration and the Factors Affecting Vaccine Uptake in a Population of Patients with Autoimmune Inflammatory Rheumatic Diseases in a Brooklyn Clinic
Background/Purpose: Patients with autoimmune inflammatory rheumatic diseases (AIIRDs) are at increased risk for developing infections. The pathophysiology of the primary disease process, as well as…Abstract Number: 1177 • 2016 ACR/ARHP Annual Meeting
Pneumocystis Jirovecii Pneumonia in Systemic Autoimmune Inflammatory Diseases
Background/Purpose: Pneumocystis jirovecii pneumonia (PJP) is most frequently associated with AIDS, however, this infection also occurs in a variety of rheumatologic conditions in the context…Abstract Number: 1178 • 2016 ACR/ARHP Annual Meeting
Is Subclinical Atherosclerosis Prevalent in a French Patient Cohort with Systemic Lupus Erythematosus?
Background/Purpose: Systemic lupus erythematosus (SLE) seems associated with an increased risk of cardiovascular disease. These data are mainly based on studies mostly from North America.…
